世界の喉頭がん治療薬市場2023-2027

◆英語タイトル:Global Laryngeal Cancer Therapeutics Market 2023-2027

Technavioが発行した調査報告書(IRTNTR70041-23)◆商品コード:IRTNTR70041-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2023年10月5日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他地域
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界の喉頭がん治療薬市場2023-2027
喉頭がん治療薬市場は、2022年から2027年の間に575.25百万米ドル成長すると予測されており、予測期間中にCAGRは5.43%で加速します。
喉頭がん治療薬市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題に加えて、約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。 この市場は、喉頭がんの有病率の増加、償還プログラムの数の増加、喉頭がんに対する意識の高まりと早期発見によって牽引されています。

Technavioの喉頭がん治療薬市場は以下のように分類されます:

タイプ別:
- 生物学的製剤
- 低分子

流通チャネル別:
- オフライン
- オンライン

地域別:
- 北米
- ヨーロッパ
- アジア
- その他の世界 (ROW)

この研究は、新しい治療法の出現が、今後数年間の喉頭がん治療薬市場の成長を促進する主な理由の1つであることを特定しています。 また、精密医療の普及が進み、治療のパイプラインに新しい治療法が存在することにより、市場での大きな需要がもたらされるでしょう。

喉頭がん治療薬市場に関するレポートは、次の分野をカバーしています:
- 喉頭がん治療薬の市場規模
- 喉頭がん治療薬市場予測
- 喉頭がん治療薬市場の産業分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、このレポートでは、Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc., Bayer AG, Bristol Myers Squibb Co., Celldex Therapeutics Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hangzhou Adlai Nortye Biopharma Co. Ltd., Hanmi Pharm Co. Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltdを含むいくつかの主要な喉頭がん治療薬市場ベンダーの詳細な分析を提供します。また、喉頭がん治療薬市場分析レポートには、市場の成長に影響を与える今後の傾向と課題などの情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

本調査は、産業の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。
当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な産業インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査報告書は、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1.エグゼクティブサマリー
2.市場状況
3.市場規模
4.過去の市場規模
5.ファイブフォース分析
6.喉頭がん治療薬市場のセグメンテーション:種類別
7.喉頭がん治療薬市場のセグメンテーション:流通チャネル別
8.顧客状況
9.地理的状況
10.推進要因・課題・傾向
11.企業状況
12.企業分析
13.付録

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global laryngeal cancer therapeutics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global laryngeal cancer therapeutics market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Biologics – Market size and forecast 2022-2027
o Exhibit 34: Chart on Biologics – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Biologics – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Biologics – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Biologics – Year-over-year growth 2022-2027 (%)
o 6.4 Small molecules – Market size and forecast 2022-2027
o Exhibit 38: Chart on Small molecules – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Small molecules – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Small molecules – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Small molecules – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Offline – Market size and forecast 2022-2027
o Exhibit 48: Chart on Offline – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Offline – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Offline – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Offline – Year-over-year growth 2022-2027 (%)
o 7.4 Online – Market size and forecast 2022-2027
o Exhibit 52: Chart on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Online – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Online – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 56: Market opportunity by Distribution Channel ($ million)
o Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 63: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 79: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 83: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 91: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 95: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 107: Amgen Inc. – Overview
o Exhibit 108: Amgen Inc. – Product / Service
o Exhibit 109: Amgen Inc. – Key offerings
o 12.4 AstraZeneca Plc
o Exhibit 110: AstraZeneca Plc – Overview
o Exhibit 111: AstraZeneca Plc – Product / Service
o Exhibit 112: AstraZeneca Plc – Key news
o Exhibit 113: AstraZeneca Plc – Key offerings
o 12.5 Bayer AG
o Exhibit 114: Bayer AG – Overview
o Exhibit 115: Bayer AG – Business segments
o Exhibit 116: Bayer AG – Key news
o Exhibit 117: Bayer AG – Key offerings
o Exhibit 118: Bayer AG – Segment focus
o 12.6 Bristol Myers Squibb Co.
o Exhibit 119: Bristol Myers Squibb Co. – Overview
o Exhibit 120: Bristol Myers Squibb Co. – Product / Service
o Exhibit 121: Bristol Myers Squibb Co. – Key news
o Exhibit 122: Bristol Myers Squibb Co. – Key offerings
o 12.7 Celldex Therapeutics Inc.
o Exhibit 123: Celldex Therapeutics Inc. – Overview
o Exhibit 124: Celldex Therapeutics Inc. – Product / Service
o Exhibit 125: Celldex Therapeutics Inc. – Key offerings
o 12.8 Eli Lilly and Co.
o Exhibit 126: Eli Lilly and Co. – Overview
o Exhibit 127: Eli Lilly and Co. – Product / Service
o Exhibit 128: Eli Lilly and Co. – Key news
o Exhibit 129: Eli Lilly and Co. – Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 130: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 131: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 132: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 133: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 134: F. Hoffmann La Roche Ltd. – Segment focus
o 12.10 Hangzhou Adlai Nortye Biopharma Co. Ltd.
o Exhibit 135: Hangzhou Adlai Nortye Biopharma Co. Ltd. – Overview
o Exhibit 136: Hangzhou Adlai Nortye Biopharma Co. Ltd. – Product / Service
o Exhibit 137: Hangzhou Adlai Nortye Biopharma Co. Ltd. – Key offerings
o 12.11 Hanmi Pharm Co. Ltd.
o Exhibit 138: Hanmi Pharm Co. Ltd. – Overview
o Exhibit 139: Hanmi Pharm Co. Ltd. – Product / Service
o Exhibit 140: Hanmi Pharm Co. Ltd. – Key offerings
o 12.12 Hikma Pharmaceuticals Plc
o Exhibit 141: Hikma Pharmaceuticals Plc – Overview
o Exhibit 142: Hikma Pharmaceuticals Plc – Business segments
o Exhibit 143: Hikma Pharmaceuticals Plc – Key offerings
o Exhibit 144: Hikma Pharmaceuticals Plc – Segment focus
o 12.13 Merck and Co. Inc.
o Exhibit 145: Merck and Co. Inc. – Overview
o Exhibit 146: Merck and Co. Inc. – Business segments
o Exhibit 147: Merck and Co. Inc. – Key news
o Exhibit 148: Merck and Co. Inc. – Key offerings
o Exhibit 149: Merck and Co. Inc. – Segment focus
o 12.14 Pfizer Inc.
o Exhibit 150: Pfizer Inc. – Overview
o Exhibit 151: Pfizer Inc. – Product / Service
o Exhibit 152: Pfizer Inc. – Key news
o Exhibit 153: Pfizer Inc. – Key offerings
o 12.15 Regeneron Pharmaceuticals Inc.
o Exhibit 154: Regeneron Pharmaceuticals Inc. – Overview
o Exhibit 155: Regeneron Pharmaceuticals Inc. – Product / Service
o Exhibit 156: Regeneron Pharmaceuticals Inc. – Key offerings
o 12.16 Sanofi
o Exhibit 157: Sanofi – Overview
o Exhibit 158: Sanofi – Business segments
o Exhibit 159: Sanofi – Key news
o Exhibit 160: Sanofi – Key offerings
o Exhibit 161: Sanofi – Segment focus
o 12.17 Sun Pharmaceutical Industries Ltd.
o Exhibit 162: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 163: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 164: Sun Pharmaceutical Industries Ltd. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 165: Inclusions checklist
o Exhibit 166: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 167: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 168: Research methodology
o Exhibit 169: Validation techniques employed for market sizing
o Exhibit 170: Information sources
o 13.5 List of abbreviations
o Exhibit 171: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global laryngeal cancer therapeutics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Biologics – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Biologics – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Biologics – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Biologics – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Small molecules – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Small molecules – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Small molecules – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Small molecules – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Offline – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Offline – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Offline – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Offline – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Online – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Online – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Online – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Online – Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Distribution Channel ($ million)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Amgen Inc. – Overview
Exhibits108: Amgen Inc. – Product / Service
Exhibits109: Amgen Inc. – Key offerings
Exhibits110: AstraZeneca Plc – Overview
Exhibits111: AstraZeneca Plc – Product / Service
Exhibits112: AstraZeneca Plc – Key news
Exhibits113: AstraZeneca Plc – Key offerings
Exhibits114: Bayer AG – Overview
Exhibits115: Bayer AG – Business segments
Exhibits116: Bayer AG – Key news
Exhibits117: Bayer AG – Key offerings
Exhibits118: Bayer AG – Segment focus
Exhibits119: Bristol Myers Squibb Co. – Overview
Exhibits120: Bristol Myers Squibb Co. – Product / Service
Exhibits121: Bristol Myers Squibb Co. – Key news
Exhibits122: Bristol Myers Squibb Co. – Key offerings
Exhibits123: Celldex Therapeutics Inc. – Overview
Exhibits124: Celldex Therapeutics Inc. – Product / Service
Exhibits125: Celldex Therapeutics Inc. – Key offerings
Exhibits126: Eli Lilly and Co. – Overview
Exhibits127: Eli Lilly and Co. – Product / Service
Exhibits128: Eli Lilly and Co. – Key news
Exhibits129: Eli Lilly and Co. – Key offerings
Exhibits130: F. Hoffmann La Roche Ltd. – Overview
Exhibits131: F. Hoffmann La Roche Ltd. – Business segments
Exhibits132: F. Hoffmann La Roche Ltd. – Key news
Exhibits133: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits134: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits135: Hangzhou Adlai Nortye Biopharma Co. Ltd. – Overview
Exhibits136: Hangzhou Adlai Nortye Biopharma Co. Ltd. – Product / Service
Exhibits137: Hangzhou Adlai Nortye Biopharma Co. Ltd. – Key offerings
Exhibits138: Hanmi Pharm Co. Ltd. – Overview
Exhibits139: Hanmi Pharm Co. Ltd. – Product / Service
Exhibits140: Hanmi Pharm Co. Ltd. – Key offerings
Exhibits141: Hikma Pharmaceuticals Plc – Overview
Exhibits142: Hikma Pharmaceuticals Plc – Business segments
Exhibits143: Hikma Pharmaceuticals Plc – Key offerings
Exhibits144: Hikma Pharmaceuticals Plc – Segment focus
Exhibits145: Merck and Co. Inc. – Overview
Exhibits146: Merck and Co. Inc. – Business segments
Exhibits147: Merck and Co. Inc. – Key news
Exhibits148: Merck and Co. Inc. – Key offerings
Exhibits149: Merck and Co. Inc. – Segment focus
Exhibits150: Pfizer Inc. – Overview
Exhibits151: Pfizer Inc. – Product / Service
Exhibits152: Pfizer Inc. – Key news
Exhibits153: Pfizer Inc. – Key offerings
Exhibits154: Regeneron Pharmaceuticals Inc. – Overview
Exhibits155: Regeneron Pharmaceuticals Inc. – Product / Service
Exhibits156: Regeneron Pharmaceuticals Inc. – Key offerings
Exhibits157: Sanofi – Overview
Exhibits158: Sanofi – Business segments
Exhibits159: Sanofi – Key news
Exhibits160: Sanofi – Key offerings
Exhibits161: Sanofi – Segment focus
Exhibits162: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits163: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits164: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits165: Inclusions checklist
Exhibits166: Exclusions checklist
Exhibits167: Currency conversion rates for US$
Exhibits168: Research methodology
Exhibits169: Validation techniques employed for market sizing
Exhibits170: Information sources
Exhibits171: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の喉頭がん治療薬市場2023-2027(Global Laryngeal Cancer Therapeutics Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆